
Central Texas Guide to Rare Neuro Updates, Advocacy, and Support

Table of Contents
📝 Editor's Note: Return to Needle Land
đź“° Main Article: Texas Voters to Decide on $3 Billion Dementia Research Institute
🧬 CIDP Focus: Texas Treatment Centers & Current Clinical Trials
⚡ Clinical Trial Spotlight: CIDP Trial Enrollment Guide
đź’ˇ Resource Spotlight: New Texas Patient Support Programs
🔬 Innovation Watch: UT Southwestern's $5M Cerebellar Research
🌵 Closing Thoughts: Building Networks Across Rural Texas
đź“… Future Topics: What's Coming

1. Editor's Note: Needles in my future 🌵
Real talk from someone who's been in the trenches with you—I'm writing this edition while dealing with what I now call "The Weaks." After a “set” of infusions and taking a 4-month break with my fingers crossed, CIDP has decided to remind me exactly who's boss. Arms and legs feeling like they're made of lead? Check. Normal to “ I need to sit down” in moments? Check. Need a pot of coffee to keep going? Double check. I really hate the word relapse, so lets just say I now have a new unwanted guest that drops in uninvited, stays a few hours and then like a bad headache we are glad to see him go.
But here's the thing about our rare disease community—we don't just survive these moments, we learn from them, share them, and somehow find ways to keep moving forward (even when "moving forward" feels like wading through molasses). Every story in this newsletter, every resource we share, every connection we make—it all comes from this real, messy, experience of living with conditions that most folks have never heard of.
So if you're reading this while dealing with your own version of "The Weaks," know that you're not alone. We're all figuring this out together, one infusion, one bad day, one small victory at a time.
Stay strong, Texas.

2. đź“° MAIN ARTICLE
Texas Voters Hold Key to $3 Billion Brain Research Revolution
November's election offers Texas families a chance to create the world's largest brain health research center. The Dementia Prevention and Research Institute of Texas (DPRIT) awaits voter approval for $3 billion in funding, awarding up to $300 million annually through grants.
With nearly half a million Texans affected by dementia and $4 billion in annual Medicare costs, DPRIT will research all brain diseases—including Parkinson's and rare neurological disorders. Following the success of Texas' Cancer Prevention and Research Institute, which recruited 324 researchers and supported 74 companies, this initiative could revolutionize rare disease research statewide.
đź”— Learn more: Texas Legislature Brain Research Initiative

3. 🧬 CIDP FOCUS
Texas CIDP Resources & Active Clinical Opportunities
CIDP affects approximately 30,000 Americans with progressive weakness and sensory impairment in arms and legs. Texas offers comprehensive care through UTHealth Houston's McGovern Medical School Neuromuscular Program and multiple active clinical trials. Current opportunities include the ARISE study for newly diagnosed and treatment-experienced patients, riliprubart Phase 3 trials (MOBILIZE/VITALIZE) testing immune system blockers, and NVG-2089 Phase 2 for treatment-refractory cases. Early treatment is crucial, with up to 4 in 5 people responding well to therapy. Texas GBS/CIDP Foundation chapters provide ongoing support statewide.
đź”— Key Resources:

4. ⚡ CLINICAL TRIAL SPOTLIGHT
CIDP Trial Enrollment Opportunities
Multiple breakthrough CIDP trials actively recruit across Texas, offering alternatives to traditional treatments. All qualifying participants receive study-required medical care at no cost, with travel expense compensation available.
Current Texas Trials:
ARISE Study: Open to all CIDP patients
Riliprubart Studies: Subcutaneous or IV options
CAPTIVATE (DNTH103): Novel treatment approach
đź”— Find trials: GBS/CIDP Foundation Clinical Trials

5. đź’ˇ RESOURCE SPOTLIGHT
New Texas Patient Support Programs
UT Southwestern earned designation as the North Texas Alzheimer's Disease Research Center with $23 million in five-year funding. This creates opportunities for patients with various neurodegenerative conditions through research participation, virtual support groups, and travel assistance programs.
đź”— Info: UT Southwestern Alzheimer's Center

6. 🔬 INNOVATION WATCH
$5M UT Southwestern Cerebellar Research Breakthrough
Dallas researchers received up to $5 million from the Raynor Cerebellum Project to develop neuromodulation therapies for cerebellar disorders. The goal: implantable therapy allowing patients to "live their lives rather than keep coming back for repeated treatments."
đź”— Details: UT Southwestern Cerebellar Research
7. 🌵 CLOSING THOUGHTS
Building Networks Across Rural Texas
Texas rare disease innovation spans from major cities to rural communities. The upcoming DPRIT election gives every Texan a voice in advancing brain health research. Whether in Houston or small-town Texas, your vote could accelerate treatments for rare neurological diseases affecting thousands of families statewide.
8. đź“… COMING UP
Election results: What DPRIT approval means for Texas families
Houston Methodist neural restoration breakthroughs
Patient advocacy spotlight from East Texas
Latest CIDP trial results and new study openings
Neighborly Note & Disclaimer: We share research and lived experience, but we’re not doctors—always check with your provider. Stories stay anonymous unless you say otherwise. Sponsors don’t guide content. Found an error? Tell us. We strive for accuracy, and your feedback keeps us honest.
Sponsor Note: Partner With Texas Neurorare
We invite mission-aligned partners to help us expand access, education, and support—without compromising editorial integrity.Please contact us for information.
